Inscripta announces strategic acquisition of Solana Biosciences

Inscripta announces strategic acquisition of Solana Biosciences

BOULDER -- Inscripta , a leading gene-editing technology company, today announced the strategic acquisition of Solana Biosciences, a life sciences company founded by Illumina (NASDAQ: ILMN)... Read More

Thursday September 6, 2018 0 comments Tags: Boulder, Inscripta, Solana Biosciences, Dr. Kevin Ness, Tom Rosso, John Stuelpnagel